Case Studies | Pfizer CentreOne

Driving the seamless tech transfer of multiple projects within a condensed timeline

Discover how Pfizer’s scientific and technical experts successfully navigated the complexities of this transition—demonstrating the expertise and capabilities accessible through Pfizer CentreOne - a CMO powered by Pfizer.

Placing Drug Strategies on a Solid Foundation for Success

Getting innovative new drugs to market faster, more economically and with uncompromising safety is prompting manufacturers to rethink their development strategies and business models to reach patients faster.

Driving the seamless tech transfer of multiple projects within a condensed timeline

A successful tech transfer requires meticulous planning, process expertise and clear communication to ensure smooth knowledge transfer and maintain product quality.

Ensuring reliable complex OSD delivery in the face of natural disaster at Pfizer CentreOne, Newbridge

Ensuring an effective and reliable supply of critical oral solid dosage (OSD) therapies requires immense expertise, specialized capabilities and optimized processes.

Customer insight: Scaling success through close cooperation

The development of life-changing drugs is crucial to improving patient health and well-being. However, there are many difficulties drug developers face on the journey from laboratory discovery to widespread patient access, including when it comes to scaling up drug manufacturing.

Customer insight: Scaling success through strategic partnerships

Overcoming supply chain roadblocks to enable reliable complex OSD delivery at Pfizer CentreOne, Ascoli.

In our in-depth case study, the experts at Pfizer CentreOne explore the importance of effective communication and flawless supply chain management in the face of some unique technical hurdles.

Assuring drug substance and product supply chains to support worldwide delivery of Sobi’s life-saving biologic

Sobi, a specialized international biopharmaceutical company transforming the lives of people with rare and debilitating diseases observed an unpredicted increase in demand.

Case Study | How Intelligent Collaboration Transformed a Generic into a Best-in-Class New Drug

Read how collaboration and the drive to find a workable solution led to a successful drug development program.